Criteo files Form 144 to sell 3,833 shares

Criteo S.A. submitted a Form 144 notifying a proposed sale of 3,833 ordinary shares linked to performance stock units and restricted stock units.

Rhea-AI Filing Summary

Criteo S.A. submitted a Form 144 notifying a proposed sale of 3,833 ordinary shares linked to performance stock units and restricted stock units. The filing ties the shares to vesting under compensation arrangements with an effective date of 02/24/2026.

The notice also reports prior sales by Sarah Glickman of 3,982 shares on 11/24/2025 for $77,696.39 and 2,796 shares on 02/23/2026 for $47,014.46.

Insights

Securities Compliance Counselor

Form 144 documents a proposed Rule 144 resale of vested compensation shares.

The filing lists 3,833 ordinary shares associated with performance stock units and restricted stock units vesting on 02/24/2026, indicating the filer intends to rely on Rule 144 resale provisions tied to compensation vesting.

Cash-flow treatment and planned sale mechanics are not detailed in the excerpt; subsequent broker confirmations or a Form 4/5 may show execution details and actual proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Criteo's (CRTO) Form 144 notify?

The Form 144 notifies a proposed resale of 3,833 ordinary shares tied to vested PSUs/RSUs dated 02/24/2026. The notice documents the shares and vesting source under compensation arrangements, without detailing sale method or broker execution.

Who reported prior share sales in the Form 144 excerpt for CRTO?

The filing shows prior sales by Sarah Glickman: 3,982 shares on 11/24/2025 for $77,696.39 and 2,796 shares on 02/23/2026 for $47,014.46. These are disclosed as past transactions.

Are the 3,833 shares registered or newly issued in the Form 144?

The excerpt links the 3,833 shares to vesting of performance and restricted stock units under compensation on 02/24/2026. The filing presents them as the securities to be sold rather than as newly issued registered shares.

Does the Form 144 state how the CRTO shares will be sold?

The provided excerpt does not specify sale mechanics or distribution methods. The filing lists the securities and vesting source but does not describe broker, block trade, or at‑the‑market methods in the visible text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:01 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001749338
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Criteo S.A.
SEC File Number	001-36153
Address of Issuer	32 RUE BLANCHE PARIS FRANCE 75009
Phone	33175850939
Name of Person for Whose Account the Securities are To Be Sold	Glickman Sarah JS
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	CHIEF FINANCIAL OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS INC 390 GREENWICH STREET NEW YORK NY 10013	1541	25753.35	52149158	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	02/24/2022	PERFORMANCE STOCK UNITS VESTING AND RESTRICTED STOCK UNITS VESTING	CRITEO S.A.			3833	02/24/2026	COMPENSATION

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SARAH GLICKMAN 32 RUE BLANCHE PARIS I0 75009	ORDINARY SHARES	11/24/2025	3982	77696.39
SARAH GLICKMAN 32 RUE BLANCHE PARIS I0 75009	ORDINARY SHARES	02/23/2026	2796	47014.46

144: Remarks and Signature

Remarks	UNDER SECURITIES TO BE SOLD DATE ACQUIRED WAS FEBRUARY 24 2022 TO SECTION 3 D BASED ON INDICATIVE MARKET PRICE 16.7121 THESE SECURITIES WERE AUTOMATICALLY SOLD TO COVER TAX WITHHOLDING OBLIGATIONS ARISING FROM THE VESTING AND SETTLEMENT OF EQUITY AWARDS
Date of Notice	02/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	CONFORMED SIGNATURE ON FILE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)